No Data
No Data
Express News | Kronos Bio Inc - Expects to Provide an Efficacy Update on This Expansion Cohort in 1H 2025 -
Express News | Kronos Bio Announces First Patient Dosed With KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
Kronos Bio(KRON.US) Officer Buys US$733.8K in Common Stock
Shareholders May Be More Conservative With Kronos Bio, Inc.'s (NASDAQ:KRON) CEO Compensation For Now
Increases to Kronos Bio, Inc.'s (NASDAQ:KRON) CEO Compensation Might Cool off for Now
President of Kronos Bio Picks Up 36% More Stock